"Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transference of cells within an individual, between individuals of the same species, or between individuals of different species.
| Descriptor ID |
D017690
|
| MeSH Number(s) |
E02.095.147.500 E04.936.225
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Cell Transplantation".
This graph shows the total number of publications written about "Cell Transplantation" by people in this website by year, and whether "Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Transplantation" by people in Profiles.
-
Lee B, Parvizi J, Bramlet D, Romness DW, Guermazi A, Noh M, Sodhi N, Khlopas A, Mont MA. Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF-?1. J Knee Surg. 2020 Feb; 33(2):167-172.
-
Wang ML, Beredjiklian PK, Steplewski A, Fertala J, Fertala A. Engineering the Second Generation of Therapeutic Cells with Enhanced Targeting of Injured Tissues. Tissue Eng Part A. 2018 08; 24(15-16):1293-1300.
-
Cherian JJ, Parvizi J, Bramlet D, Lee KH, Romness DW, Mont MA. Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-?1 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis Cartilage. 2015 Dec; 23(12):2109-2118.
-
Thomassen MJ, Kavuru MS. Lung disease: Treatment by cell transplant. Nature. 2014 Oct 23; 514(7523):438-40.
-
Petrof G, Abdul-Wahab A, McGrath JA. Cell therapy in dermatology. Cold Spring Harb Perspect Med. 2014 Jun 02; 4(6).
-
Shukla V, Ma S, Hardy RR, Joshi SS, Lu R. A role for IRF4 in the development of CLL. Blood. 2013 Oct 17; 122(16):2848-55.
-
Frisbie DD, Stewart MC. Cell-based therapies for equine joint disease. Vet Clin North Am Equine Pract. 2011 Aug; 27(2):335-49.
-
Nagy N, Almaani N, Tanaka A, Lai-Cheong JE, Techanukul T, Mellerio JE, McGrath JA. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol. 2011 Aug; 131(8):1771-4.
-
Greenbaum LE. From skin cells to hepatocytes: advances in application of iPS cell technology. J Clin Invest. 2010 Sep; 120(9):3102-5.
-
Chen ES, Terry MA, Shamie N, Hoar KL, Phillips PM, Friend DJ. Endothelial keratoplasty: vision, endothelial survival, and complications in a comparative case series of fellows vs attending surgeons. Am J Ophthalmol. 2009 Jul; 148(1):26-31.e2.